![](/img/cover-not-exists.png)
The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes
Rodbard, Helena W., Peters, Anne L., Slee, April, Cao, Anjun, Traina, Shana B., Alba, MariaLanguage:
english
Journal:
Diabetes Care
DOI:
10.2337/dc16-1353
Date:
November, 2016
File:
PDF, 903 KB
english, 2016